The researchers studied 133 patients treated for NSCLC spinal metastases between 2010 and 2014. The study divided patients into two groups based on whether they underwent spinal surgery. They assessed quality of life with the Functional Assessment of Cancer Therapy-General questionnaire.
Here are four observations:
1. Of the patients, 86 survived for nine months and were assessed at one month, three months, six months and nine months post-diagnosis.
2. The patients who received surgery reported higher total, physical well-being, emotional well-being and functional well-being quality-of-life scores at all assessments, compared to the non-surgery group.
3. The surgery group also experienced longer survival than the non-surgery group.
4. The researchers concluded surgery improves the quality of life of patients with NSCLC spinal metastases over a nine-month assessment period.
More articles on spine:
8 things for spine surgeons to know for Thursday — March, 3, 2016
BCBS recognizes Cabell Huntington Hospital’s spine surgery program: 3 notes
HSS names Dr. Joel Press new physiatrist-in-chief: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
